期刊论文详细信息
Translational Neurodegeneration
Intranuclear inclusions in a fragile X mosaic male
Flora Tassone6  Paul J Hagerman3  Deborah A Hall5  Stephen C Noctor1  Randi J Hagerman2  Claudia M Greco1  Christopher L Cunningham4  Michael R Hunsaker6  Dalyir I Pretto3 
[1] Department of Pathology, School of Medicine, University of California at Davis, Davis, CA, USA;Department of Pediatrics, School of Medicine, University of California at Davis, Davis, CA, USA;Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, One Shields Avenue, Davis, CA, USA;Neuroscience Graduate Program, University of California, Davis, Davis, CA, USA;Department of Biochemistry, Neurological Sciences, Rush University, Chicago, IL, USA;MIND Institute, University of California Davis Medical Center, Sacramento, CA, USA
关键词: Premutation;    FXTAS;    FXS;    Intranuclear inclusions;   
Others  :  838708
DOI  :  10.1186/2047-9158-2-10
 received in 2013-02-13, accepted in 2013-05-17,  发布年份 2013
PDF
【 摘 要 】

Lack of the fragile X mental retardation protein leads to Fragile X syndrome (FXS) while increased levels of FMR1 mRNA, as those observed in premutation carriers can lead to Fragile X- associated tremor ataxia syndrome (FXTAS). Until recently, FXTAS had been observed only in carriers of an FMR1 premutation (55–200 CGG repeats); however the disorder has now been described in individuals carriers of an intermediate allele (45–54 CGG repeats) as well as in a subject with a full mutation with mosaicism.

Here, we report on molecular and clinical data of a male FMR1 mosaic individual with full and premutation alleles. Molecular analysis of FMR1 and FMRP expression in this subject is consistent with a FXS phenotype. We observed reduced expression of FMRP in both peripheral blood and brain leading to the FXS diagnosis. In addition, a dramatic 90% depletion of both FMR1 mRNA and FMRP levels was observed in the blood, as normally observed in FXS cases, and an even greater depletion in the brain. A clinical report of this patient, at age 71, described neurodegenerative signs of parkinsonism that were likely, in retrospect, part of a FXTAS scenario as post-mortem examination shows the presence of intranuclear inclusions, the hallmark pathology of FXTAS.

The findings presented in this study indicate co-morbidity for both FXS and FXTAS in this individual carrying both full and premutation FMR1 alleles. In addition, based on symptoms and pathological and molecular evidence, this report suggests the need to redefine the diagnostic criteria of FXTAS.

【 授权许可】

   
2013 Pretto et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140716023500491.pdf 1650KB PDF download
Figure 4. 97KB Image download
Figure 3. 166KB Image download
Figure 2. 34KB Image download
Figure 1. 76KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Sobesky WE, Taylor AK, Pennington BF, Bennetto L, Porter D, Riddle J, Hagerman RJ: Molecular/clinical correlations in females with fragile X. Am J Med Genet 1996, 64:340-345.
  • [2]Guerreiro MM, Camargo EE, Kato M, Marques-de-Faria AP, Ciasca SM, Guerreiro CA, Netto JR, Moura-Ribeiro MV: Fragile X syndrome. Clinical, electroencephalographic and neuroimaging characteristics. Arq Neuropsiquiatr 1998, 56:18-23.
  • [3]McLennan Y, Polussa J, Tassone F, Hagerman R: Fragile x syndrome. Curr Genomics 2011, 12:216-224.
  • [4]Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ: Autism profiles of males with fragile X syndrome. Am J Ment Retard 2008, 113:427-438.
  • [5]Rogers SJ, Wehner DE, Hagerman R: The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr 2001, 22:409-417.
  • [6]Hagerman PJ, Hagerman RJ: Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev 2004, 10:25-30.
  • [7]Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R: Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 2003, 72:869-878.
  • [8]Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J: Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 2006, 129:243-255.
  • [9]Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont S, Leehey M, Hagerman PJ: Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002, 125:1760-1771.
  • [10]Greco CM, Soontrapornchai K, Wirojanan J, Gould JE, Hagerman PJ, Hagerman RJ: Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome. J Urol 2007, 177:1434-1437.
  • [11]Hunsaker MR, Greco CM, Spath MA, Smits AP, Navarro CS, Tassone F, Kros JM, Severijnen LA, Berry-Kravis EM, Berman RF: Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol 2011, 122:467-479.
  • [12]Berman RF, Willemsen R: Mouse models of fragile X-associated tremor ataxia. J Investig Med 2009, 57:837-841.
  • [13]Tassone F, Iwahashi C, Hagerman PJ: FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol 2004, 1:103-105.
  • [14]Iwahashi CK, Yasui DH, An HJ, Greco CM, Tassone F, Nannen K, Babineau B, Lebrilla CB, Hagerman RJ, Hagerman PJ: Protein composition of the intranuclear inclusions of FXTAS. Brain 2006, 129:256-271.
  • [15]Jin P, Duan R, Qurashi A, Qin Y, Tian D, Rosser TC, Liu H, Feng Y, Warren ST: Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 2007, 55:556-564.
  • [16]Sellier C, Rau F, Liu Y, Tassone F, Hukema RK, Gattoni R, Schneider A, Richard S, Willemsen R, Elliott DJ: Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 2010, 29:1248-1261.
  • [17]Sellier C, Freyermuth F, Tabet R, Tran T, He F, Ruffenach F, Alunni V, Moine H, Thibault C, Page A: Sequestration of DROSHA and DGCR8 by expanded CGG-repeats RNA alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Reportsin press
  • [18]Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman PJ: Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 2000, 91:144-152.
  • [19]Kenneson A, Zhang F, Hagedorn CH, Warren ST: Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 2001, 10:1449-1454.
  • [20]Primerano B, Tassone F, Hagerman RJ, Hagerman P, Amaldi F, Bagni C: Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA 2002, 8:1482-1488.
  • [21]Peprah E, He W, Allen E, Oliver T, Boyne A, Sherman SL: Examination of FMR1 transcript and protein levels among 74 premutation carriers. J Hum Genet 2010, 55:66-68.
  • [22]Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ: Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001, 57:127-130.
  • [23]Hall D, Pickler L, Riley K, Tassone F, Hagerman R: Parkinsonism and cognitive decline in a fragile X mosaic male. Mov Disord 2010, 25:1523-1524.
  • [24]Liu Y, Winarni T, Zhang L, Tassone F, Hagerman R: Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers. Clin Genet 2012,  :1-4.
  • [25]Loesch DZ, Sherwell S, Kinsella G, Tassone F, Taylor A, Amor D, Sung S, Evans A: Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin Genet 2012, 82:88-92.
  • [26]Hunsaker MR, Greco CM, Tassone F, Berman RF, Willemsen R, Hagerman RJ, Hagerman PJ: Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders. J Neuropathol Exp Neurol 2011, 70:462-469.
  • [27]Hagerman PJ, Hagerman RJ: The fragile-X premutation: a maturing perspective. Am J Hum Genet 2004, 74:805-816.
  • [28]Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ: A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 2008, 10:43-49.
  • [29]Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, Hagerman PJ, Stenzel TT, Hadd AG, Latham GJ, Tassone F: A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 2010, 56:399-408.
  • [30]Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ: Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000, 66:6-15.
  • [31]Hunsaker MR, Wenzel HJ, Willemsen R, Berman RF: Progressive spatial processing deficits in a mouse model of the fragile X premutation. Behav Neurosci 2009, 123:1315-1324.
  • [32]Schluter EW, Hunsaker MR, Greco CM, Willemsen R, Berman RF: Distribution and frequency of intranuclear inclusions in female CGG KI mice modeling the fragile X premutation. Brain Res 2012, 1472:124-137.
  • [33]Wenzel HJ, Hunsaker MR, Greco CM, Willemsen R, Berman RF: Ubiquitin-positive intranuclear inclusions in neuronal and glial cells in a mouse model of the fragile X premutation. Brain Res 2010, 1318:155-166.
  • [34]Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ: Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav 2012, 11:577-585.
  • [35]Greco CM, Navarro CS, Hunsaker MR, Maezawa I, Shuler JF, Tassone F, Delany M, Au JW, Berman RF, Jin LW: Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol Autism 2011, 2:2-14. BioMed Central Full Text
  • [36]Hagerman PJ: Current gaps in understanding the molecular basis of FXTAS. Tremor Other Hyperkinet Mov (N Y) 2012, 2:1-7.
  • [37]Tassone F, Hagerman R: The fragile X-associated tremor ataxia syndrome. Results Probl Cell Differ 2012, 54:337-357.
  文献评价指标  
  下载次数:23次 浏览次数:9次